Medigenetics | Comprehensive DNA profile for drug therapy
The Right Drug
to the Right Person
Polymorphism & drug response
Wide individual variations exist in the expression and function of CYP450 enzymes. Research shows genetic variation, or polymorphism, in these enzymes is one of the most important causes of variable drug response.
Comprehensive Pharmacogenetic Report
We can provide you with a DNA profile for drug therapy, delivered in a Comprehensive Pharmacogenetic Report (40 pages).
Which category’s will be tested?
Our Pharmacogenetic Report will provide you with elaborate test details on all important fields.
Dosages based on a person’s genetics
Current methods of basing dosages on weight and age will be replaced with dosages based on a person’s genetics; how well the body processes the medicine and the time it takes to metabolize it.
This will maximize the therapy’s value and decrease the likelihood of overdose or side-effects.
Metabolic activity
The metabolic activity of a particular CYP450 enzyme can be categorized as poor, intermediate, extensive, or ultra-rapid.
Some people are considered normal metabolizers of drugs, others are intermediate metabolizers, still others are poor metabolizers (experiencing no clinical effect from the drug), and some are ultra-rapid metabolizers (experiencing toxic drug effects).
Who can use the Pharmacogenetic Report?
The information presented on the report is provided as general educational health information.
Risks for each condition
Our Pharmacogenetic Report indicates the risks for each condition, described with clear symbols and explanation.